Corneal Cross-Linking, Second Edition represents an innovative approach to treating primary acquired and secondary induced ectatic disorders. In addition, corneal cross-linking (CXL) has promising applications as an alternative in the treatment of corneal infectious and non-infectious melting, as well as conditions such as Fuchs’ endothelial dystrophy. The new and expanded Second Edition of Corneal Cross-Linking by Drs. Farhad Hafezi and J. Bradley Randleman will provide a concise yet comprehensive summary of the CXL process, including the basic science foundations, treatment protocols and outcomes, recognition and management of potential complications, and modification of standard protocol for special circumstances. Given all the changes in this rapidly progressing field, many brief topics from the first edition have now grown into full chapters or sections. These include expanded sections on alternative treatment protocols, corneal imaging and biomechanics, combing cross-linking with other refractive treatments, and a section devoted specifically to the most highly debated controversies in the field today. With each chapter being fully updated plus including over twenty new chapters that covers the latest advances and future directions, Corneal Cross-Linking, Second Edition represents the cutting-edge of CXL research and clinical practice. “Since the publication of the first edition of this book in 2013, our knowledge of corneal cross-linking has again significantly increased, both scientifically and clinically. Today, concise recommendations (guidelines for cross-linking) help the clinician to select the patients, make decisions, and provide optimal treatment” -Eberhard Spoerl, PhD and Theo Seiler, MD, PhD
Corneal Cross-Linking, Second Edition represents an innovative approach to treating primary acquired and secondary induced ectatic disorders. In addition, corneal cross-linking (CXL) has promising applications as an alternative in the treatment of corneal infectious and non-infectious melting, as well as conditions such as Fuchs’ endothelial dystrophy. The new and expanded Second Edition of Corneal Cross-Linking by Drs. Farhad Hafezi and J. Bradley Randleman will provide a concise yet comprehensive summary of the CXL process, including the basic science foundations, treatment protocols and outcomes, recognition and management of potential complications, and modification of standard protocol for special circumstances. Given all the changes in this rapidly progressing field, many brief topics from the first edition have now grown into full chapters or sections. These include expanded sections on alternative treatment protocols, corneal imaging and biomechanics, combing cross-linking with other refractive treatments, and a section devoted specifically to the most highly debated controversies in the field today. With each chapter being fully updated plus including over twenty new chapters that covers the latest advances and future directions, Corneal Cross-Linking, Second Edition represents the cutting-edge of CXL research and clinical practice. “Since the publication of the first edition of this book in 2013, our knowledge of corneal cross-linking has again significantly increased, both scientifically and clinically. Today, concise recommendations (guidelines for cross-linking) help the clinician to select the patients, make decisions, and provide optimal treatment” -Eberhard Spoerl, PhD and Theo Seiler, MD, PhD
This book presents the first full and systematic account of Iran’s nuclear program from 1979 to 2015. Throughout this time, foreign policy makers, intelligence experts, and scholars on the subject have repeatedly failed to understand the internal dynamics behind Iran's nuclear project and have underestimated the depth of the regime’s commitment to develop nuclear weapons. The author presents an account of little-understood episodes in the history of the nuclear project, including an analysis of the decision making process of the “nuclear sanctum.” A full account is given of the organizations that ran the project and a listing of the suppliers that made the project possible. Finally, the book offers a detailed analysis of the international sanctions placed on Iran, including the induced anomie and legitimacy crisis which expedited the decision to rollback.
This book analyzes the process of evaluating Iran’s nuclear project and the efforts to roll it back, resulting in the 2015 nuclear agreement known as the Joint Comprehensive Plan of Action (JCPA). Despite its aura of scientific exactitude, nuclear intelligence is complex and susceptible to methodological disagreements and political bias at the international oversight level—the International Atomic Energy Agency (IAEA)—and within the countries involved in the rollback project – Israel and the United States. To highlight both the technological problems of assessing compliance and the politicization, each chapter in the book uses a real-time comparison of the nuclear developments in Iran, and the perception of Israel and the United States. This methodology yielded some significant results. Essentially, two camps had formed in each country; those who were pushing for an agreement with Iran and those who opposed it. The Israeli intelligence agencies – the Mossad and the Military Intelligence – as well as the highly secretive Israeli Atomic Energy Commission (IAEC) which advised them considered the program to be weak and slow moving. The right-wing government of Benjamin Netanyahu suggested that Iran was steps away from the “point of no return,” making it an existential threat to Israel. A virtually identical split emerged in Washington. While the intelligence community and the advising scientists from the National Nuclear Laboratories, considered Iran progress to be relatively modest, the Republicans and the Israel lobby - the Jewish organizations and the Christian Zionists— warned of the imminent danger of a nuclear Iran. With the Obama administration pushing for the JCPOA, a fierce debate took place in Congress. The Israeli intelligence and military chiefs led by the Mossad chief Meir Dagan, which had previously blocked Netanyahu from a preemptive action, quietly supported the agreement. In Washington, the Israel lobby, and the Republicans, helped by Netanyahu, mounted an all-out effort to defeat the deal in Congress. The pro-deal coalition fought back by mobilizing the scientific community, military and intelligence officials, the business lobby, and grassroots Democrats. The JCPOA represents the first successful effort of peaceful counterproliferation. At the same, excessive politicization has clouded its legitimacy and cast doubt about its future.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.